Has the current market environment begun to favor less speculative companies and investment managers with a more active orientation? Director of Investments, Managing Director, and Portfolio Manager Whitney Georgetalks about valuations, sectors and industries that he believes look promising, and some names in which he has high conviction.
Many of the portfolios you manage or co-manage have done very well so far in 2014. What conditions have helped to drive the rebound?The market has definitely been improving for our style of investing��e'd like to think it's also normalizing; that is, returning to a more historically typical performance cycle in which company fundamentals matter. This started more than a year ago when taper talk began and interest rates started to rise.
Around that same time it became pretty clear that legislative agendas were being closed down in Washington, creating a gridlock that seems to have removed some uncertainty. Businesses no longer have to guess what might happen politically because it's become almost impossible to get anything done. This isn't likely to change until after this year's mid-term elections at the earliest. Correlation levels across all asset classes are also declining. It feels like a better market for active management overall.
Top Medical Companies To Invest In Right Now: National Health Partners Inc (NHPR)
National Health Partners, Inc., incorporated on March 10, 1989, is a national healthcare membership organization that was formed to address the need for affordable healthcare nationwide. The Company creates, markets and sells membership programs targeted toward underserved markets in the healthcare industry through a national healthcare savings network called CARExpress. CARExpress is a network of over 1,000,000 participating hospitals, doctors, dentists, pharmacists and other healthcare providers that have agreed to render their services and products to the Company's members at discounted prices. CARExpress enables the Company's members to engage in point-of-service transactions directly with participating healthcare providers and pay discounted prices.
The Company has designed membership programs that range from its traditional health discount programs that provide access to networks of providers that have agreed to provide its members with a reduced rate for services, to membership programs that include limited liability insurance benefits. The Company offers two families of CARExpress membership programs to its members, its CARExpress health discount programs, and its CARExpress Plus membership programs.
The Company's CARExpress health discount programs consists of healthcare, including physicians, hospitals, ancillary services, dentists, prescription drugs, vision care, hearing aids, chiropractic services, alternative care, 24-hour nurseline, medical supplies and equipment, and long-term care facilities, which include skilled nursing facilities, assisted living facilities, respite care and home health care. The Company provides its members with access to over 1,000,000 healthcare providers through its agreements with CareMark, Aetna, Optum, Outlook Vision, Integrated Health, Three Rivers, International Med-Care and HealthFi International.
The Company's CARExpress Plus programs are membership programs consists of the Company's CARExpress health discount progr! ams and limited liability insurance benefits underwritten by United States.The limited liability insurance benefits included in these programs are accidental death and dismemberment coverage (AD&D), accident medical expense coverage (AME), accident disability coverage, a daily hospital and intensive care unit (ICU) benefit, doctor visit benefits, inpatient/outpatient surgical visit benefits, as well as emergency room and ambulance benefits. With CARExpress Plus, the Company's health discount programs provide its members with a point of service discount on their healthcare expenses at the time of service. The Company offers three standard CARExpress Plus programs, which include CARExpress Plus Platinum Program, CARExpress Plus Gold Program and CARExpress Plus Silver Program.
The Company competes with Alliance HealthCard, Inc., AmeriPlan, Best Benefits, Careington International, Family Care, Full Access Medical, International Association of Businesses, New Benefits, Inc. and People's Benefit Services.
Advisors' Opinion:- [By Peter Graham]
Last Friday, small cap stocks National Health Partners, Inc (OTCMKTS: NHPR) surged 816.7% while Timios National Corp (OTCMKTS: HOMS) and Medical Care Technologies Inc (OTCMKTS: MDCE) sank 32.28% and 25%, respectively. So what will these three small caps do for investors and traders this week? Here is a closer look to help you decide on a trading strategy:
National Health Partners, Inc (OTCMKTS: NHPR) Surged 816.7% On FridaySmall cap National Health Partners is a national healthcare savings organization that provides discount healthcare membership programs to uninsured and underinsured people through a national healthcare savings network called "CARExpress." On Friday, National Health Partners surged 816.7% to $0.044 for a market cap of $107,933 plus NHPR is down 78% over the past year and up 923.3% since June 2012 according to Google Finance.
5 Best Promising Stocks To Own For 2014: Grupo Financiero Galicia S.A. (GGAL)
Grupo Financiero Galicia S.A. operates as a financial services holding company in Argentina. The company offers financial products and services, including collection and payment services, commercial credit cards, direct payroll deposits, capital market alternatives, foreign trade solutions, and corporate e-banking solutions; corporate debt transactions and securitization transactions; and e-collection and payment solutions to various agencies, municipalities, and universities. It also provides a range of financial products and services, such as transactions, loans, and investments; and checking and savings accounts, credit and debit cards, payroll direct deposits, insurance, and retirement and pension payments. In addition, the company offers mutual funds and in brokerage services; manages positions in foreign currency and government securities; acts as an intermediary and distributes financial instruments for institutional investors, corporate customers, and individuals; and enables customers to buy and sell securities on the Buenos Aires Stock Exchange. Further, it provides life insurance products, including employee benefit plans and credit related insurance; and property and casualty insurance products, such as home and ATM theft insurance. As of December 31, 2012, the company operated 257 full service banking branches and 1,676 ATMs and self-service terminals. Grupo Financiero Galicia S.A. was founded in 1905 and is based in Buenos Aires, Argentina.
Advisors' Opinion:- [By Federico Zaldua]
Grupo Financiero Galicia (GGAL), which was once owned by Rob Citrone's hedge fund Discovery Capital Management, owns one of Argentina's biggest private banks by deposits and the fastest growing within the banks that count with national presence. As a matter of fact, according to management, "the bank's estimated market share of loans to private sector was 9.10% growing 56 basis points from a year before and the market share of deposits from the private sector was 8.98% growing 28 basis points in the year."
5 Best Promising Stocks To Own For 2014: Prothena Corporation PLC (PRTA)
Prothena Corporation PLC, incorporated on September 26, 2012, is an Ireland-based, clinical-stage biotechnology company. The Company is engaged in discovering and developing monoclonal antibodies that are directed towards misfolded proteins or improper cell adhesion. Its pipeline includes NEOD001, PRX002 and PRX003. The Company�� work in protein misfolding could result in therapies to treat several neurodegenerative diseases, including AL (primary) and AA (secondary) forms of amyloidosis (NEOD001), Parkinson's disease and related synucleinopathies (PRX002). Its cell adhesion development activities could generate new therapies to treat inflammatory diseases and metastatic cancers (PRX003). The Company�� program, NEOD001, is in Phase 1. In addition to antibodies directed to neo-epitope targets, it is developing antibodies directed to other targets. The Company has generated antibodies against cell adhesion targets expressed on certain pathogenic Th17 immune cells and tumor cells.
The Company�� pipeline also includes several late discovery stage programs for which it is testing antibodies in preclinical models of disease. It is also generating additional antibodies against other targets involved in protein misfolding and cell adhesion for characterization in vivo and in vitro.
NEOD001 for Amyloidosis
NEOD001 is a monoclonal antibody that targets the amyloid that accumulates in both AL and AA forms of amyloidosis. The antibody was designed to not react with normal serum amyloid A and only with the aberrant cleaved form of the protein (amyloid A).
PRX002 for Parkinson�� Disease
The Company has generated antibodies targeting alpha-synuclein that may slow or reduce the neurodegeneration associated with synuclein misfolding and/or transmission. It has tested these antibodies in various cellular and animal models of synuclein-related disease. In a transgenic mouse model of Parkinson�� disease, passive immunization with 9E4, a murine ver! sion of PRX002, reduced the appearance of synuclein pathology, protected synapses and improved performance by the mice in behavioral testing. The humanized antibody product candidate PRX002 has advanced into manufacturing and preclinical testing.
PRX003 for Inflammatory Diseases and Cancers
The Company is developing PRX003, a monoclonal antibody targeting MCAM for the potential treatment of inflammatory diseases and cancers. It has generated monoclonal antibodies that block MCAM-mediated cell adhesion and have been shown to delay relapse and severity of relapse in a mouse model of multiple sclerosis known as experimental autoimmune encephalomyelitis. The Company�� antibodies are being tested in animal models of inflammatory diseases and cancers. Based on early results from these studies, it has identified a clinical candidate, PRX003. It has advanced this antibody into manufacturing and intends to advance this antibody into preclinical testing.
Advisors' Opinion:- [By MONEYMORNING]
For its part, CSD also is tapping into the biotech boom. The second firm that it holds and we like is Prothena Corporation PLC (Nasdaq: PRTA), a clinical-stage biotechnology firm focused on Parkinson's disease and other neurodegenerative disorders.
5 Best Promising Stocks To Own For 2014: TechnoConcepts Inc (TCPS)
TechnoConcepts, Inc. (TCI), incorporated in May 2003, is in the business of designing, developing, manufacturing and marketing wireless communications semiconductors. The Company has begun manufacturing wireless transmitter and receiver microchips, based on its technology, and produced its engineering run in August 2006. The technology, which TCI calls True Software Radio, is designed to improve the way that wireless signals are received and transmitted, by making possible device-to-device communication across otherwise incompatible networks and wireless standards. On October 17, 2005, the Company, through its wholly owned subsidiary, Asante Acquisition Corp. completed reorganization with RegalTech Inc. RegalTech's name was changed to Asante Networks Inc. (Asante).
In December 2005, the Company formed Jinshilin Techno Ltd. (Jinshilin Techno) as its wholly owned subsidiary based in Shanghai, China. The Company organized Jinshilin Techno to provide marketing, sales and technical support for True Software Radio technology in China. On April 21, 2006, Jinshilin Techno acquired Internet television (IPTV) set-top box (STB) technology through license agreements with Jinshilin Technologies Development Company Ltd. (Jinshilin). Jinshilin Techno offers an IPTV set-top box that features voice over Internet protocol (VOIP), capability and can receive Internet protocol (IP) data transmissions through the household electrical power grid.
Asante Networks Inc. provides Ethernet networking solutions for Apple Computer and the small-to-medium business retail markets, offering the IntraCore and FriendlyNET product families, integrating voice, data, and video over wireless and wired networks with unified management and authentication. In April 2006, Asante announced the release of 2-chip switch solution, the IntraCore 38480. The IntraCore 38480 provides no frame loss and full-wire speed with minimized latency. With 96-gigabit switching fabric, the IntraCore 38480 supports full-wire speed on all ! ports. It has advanced traffic control based on L2-L7 data of incoming frames.
The Company's True Software Radio technology makes possible for wireless transmitters and receivers, as well as the radio signal processing, to be fully controlled and reconfigured by software commands across a range of frequencies and frequency bands. Its True Software Radio technology is a delta-sigma microchip architecture that converts radio frequency signals directly into digital data for the wireless receiver and directly from digital data into radio signals for the wireless transmitter. True Software Radio microchips replace the analog front end, intermediate frequency (I/F) processing, analog-to-digital conversion (ADC), and digital filtering sections of conventional wireless transmitters and receivers.
Advisors' Opinion:- [By Peter Graham]
Small cap tech stocks TechnoConcepts, Inc (OTCMKTS: TCPS), Unisource Corporation (OTCMKTS: USRC) and Strategic Global Investments, Inc (OTCMKTS: STBV) have been getting some attention lately in various investment newsletters thanks to promotions. Of course, there is nothing wrong with properly disclosed promotions, but they can backfire on the unwary as its really up to investors or traders alike to do their own due diligence before investing or trading. With that in mind, here is a quick reality check about three small cap tech stocks getting a bit of attention lately:
TechnoConcepts, Inc (OTCMKTS: TCPS) Has the Yield Sign Replaced on Its OTC PageSmall cap TechnoConcepts is a wireless technology company currently holding patents and other intellectual property. On Friday, TechnoConcepts fell 0.45% to $15.58 for a market cap of $415.28 million plus TCPC is up 1.1% over the past year and up 6% since April 2012 according to Google Finance.
No comments:
Post a Comment